Exhibit 99.1

 

Natural Health Trends Reports Second Quarter 2024 Financial Results

 

  Total net sales were flat compared to the second quarter of 2023; first year-over-year increase in Hong Kong net sales since the first quarter of 2023
  Cash flows from operations before 2017 Tax Act installment were positive for second consecutive quarter
  Declared a quarterly cash dividend of $0.20 per share

 

HONG KONG – July 31, 2024 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended June 30, 2024.

 

Second Quarter 2024 Financial Highlights

 

 

Revenue of $10.5 million is unchanged compared to the second quarter of 2023

 

 

Operating loss improved to $238,000 compared to $743,000 in the second quarter of 2023.

 

 

Net income was $173,000, or $0.02 per diluted share, compared to net loss of $219,000, or $0.02 per diluted share, in the second quarter of 2023.

 

 

The number of Active Members1 was down 2% to 31,110 at June 30, 2024 compared to 31,620 at March 31, 2024, and decreased 15% compared to 36,730 at June 30, 2023.

 

 

1

Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

 

Year-to-Date 2024 Financial Highlights

 

 

Revenue of $21.4 million decreased 4% compared to $22.4 million in the first six months of 2023. 

 

 

Operating loss was $603,000 compared to $1.1 million in the first six months of 2023.

 

 

Net income was $361,000, or $0.03 per diluted share, compared to $38,000, or breakeven per diluted share, in the first six months of 2023.

 

Management Commentary

 

“Our results indicate that the programs, promotions and incentives we’ve implemented this year have been effective and are performing as expected, maintaining engagement and driving customer satisfaction. We recognize that we’re still operating in a challenging environment, but believe we’re on the right track supporting our business and field leaders so they can find success. Our strong financial statements reflect positively on our ability to navigate the harder than expected business landscape by efficiently managing costs,” commented Chris Sharng, President of Natural Health Trends Corp.

 

Mr. Sharng continued, “In the second half of the year we will continue to execute our strategic plans with an emphasis on comprehensive training, collaborative coordination between our staff, field leaders and members, and implementation of brand building initiatives to take advantage of market opportunities.”

 

 

1

 

Balance Sheet and Cash Flow

 

 

Net cash used in operating activities was $3.0 million in the first six months of 2024 compared to $3.3 million in the first six months of 2023. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Tax Act”), cash provided by operating activities was $950,000 in the first six months 2024, versus cash used in operating activities of $307,000 in the comparable period a year ago. Of the total Tax Act liability of $20.2 million, $15.1 million has been paid to date.

 

Total cash, cash equivalents and marketable securities were $48.7 million at June 30, 2024, down from $54.4 million at March 31, 2024.

 

On July 29, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on August 23, 2024 to stockholders of record as of August 13, 2024.

 

Second Quarter 2024 Financial Results Conference Call

 

Management will host a conference call to discuss the second quarter 2024 financial results today, Wednesday, July 31, 2024 at 11:30 a.m. Eastern Time. The conference call details are as follows:

 

Date:

Wednesday, July 31, 2024

Time:

11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time

Dial-in:

1-877-407-0789 (Domestic)

1-201-689-8562 (International)

Conference ID:

13746911

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1673848&tp_key=7f60fa0c81

 

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on July 31, 2024 through 11:59 p.m. Eastern Time on August 7, 2024 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13746911.

 

About Natural Health Trends Corp.

 

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

 

Forward-Looking Statements

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

 

2

 

CONTACT:

 

Scott Davidson

Senior Vice President and Chief Financial Officer

Natural Health Trends Corp.

Tel (Hong Kong): +852-3107-0800

Tel (U.S.): 310-541-0888

investor.relations@nhtglobal.com

 

3

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data) 

 

   

June 30, 2024

   

December 31, 2023

 
   

(Unaudited)

         

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 15,577     $ 56,178  

Marketable securities

    33,087        

Inventories

    4,250       4,293  

Other current assets

    3,984       3,758  

Total current assets

    56,898       64,229  

Property and equipment, net

    225       266  

Operating lease right-of-use assets

    3,031       3,319  

Restricted cash

    36       39  

Deferred tax asset

    345       369  

Other assets

    956       869  

Total assets

  $ 61,491     $ 69,091  

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 653     $ 990  

Income taxes payable

    4,953       3,716  

Accrued commissions

    2,150       2,067  

Other accrued expenses

    1,300       1,170  

Deferred revenue

    7,587       6,166  

Amounts held in eWallets

    3,603       3,945  

Operating lease liabilities

    1,210       1,146  

Other current liabilities

    673       784  

Total current liabilities

    22,129       19,984  

Income taxes payable

          5,054  

Deferred tax liability

    135       135  

Operating lease liabilities

    1,977       2,318  

Total liabilities

    24,241       27,491  

Stockholders’ equity:

               

Preferred stock

           

Common stock

    13       13  

Additional paid-in capital

    84,770       84,695  

Accumulated deficit

    (21,948 )     (17,703 )

Accumulated other comprehensive loss

    (1,249 )     (1,069 )

Treasury stock, at cost

    (24,336 )     (24,336 )

Total stockholders’ equity

    37,250       41,600  

Total liabilities and stockholders’ equity

  $ 61,491     $ 69,091  

 

4

 

NATURAL HEALTH TRENDS CORP. 

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except per share data)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Net sales

  $ 10,475     $ 10,511     $ 21,426     $ 22,372  

Cost of sales

    2,699       2,666       5,611       5,697  

Gross profit

    7,776       7,845       15,815       16,675  

Operating expenses:

                               

Commissions expense

    4,203       4,508       8,689       9,500  

Selling, general and administrative expenses

    3,811       4,080       7,729       8,312  

Total operating expenses

    8,014       8,588       16,418       17,812  

Loss from operations

    (238 )     (743 )     (603 )     (1,137 )

Other income, net

    519       442       1,082       1,123  

Income (loss) before income taxes

    281       (301 )     479       (14 )

Income tax provision (benefit)

    108       (82 )     118       (52 )

Net income (loss)

  $ 173     $ (219 )   $ 361     $ 38  

Net income (loss) per common share:

                               

Basic

  $ 0.02     $ (0.02 )   $ 0.03     $ 0.00  

Diluted

  $ 0.02     $ (0.02 )   $ 0.03     $ 0.00  

Weighted average common shares outstanding:

                               

Basic

    11,464       11,432       11,460       11,428  

Diluted

    11,483       11,432       11,481       11,439  

 

5

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

 

   

Six Months Ended June 30,

 
   

2024

   

2023

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net income

  $ 361     $ 38  

Adjustments to reconcile net income to net cash used in operating activities:

               

Depreciation and amortization

    69       91  

Net accretion of marketable securities

    (215 )      

Share-based compensation

    75       85  

Noncash lease expense

    545       564  

Deferred income taxes

    16       (82 )

Changes in assets and liabilities:

               

Inventories

    6       (228 )

Other current assets

    (294 )     (362 )

Other assets

    (101 )     (52 )

Accounts payable

    (335 )     (82 )

Income taxes payable

    (3,817 )     (3,076 )

Accrued commissions

    106       (374 )

Other accrued expenses

    136       68  

Deferred revenue

    1,432       1,270  

Amounts held in eWallets

    (339 )     (541 )

Operating lease liabilities

    (560 )     (595 )

Other current liabilities

    (104 )     (64 )

Net cash used in operating activities

    (3,019 )     (3,340 )

CASH FLOWS FROM INVESTING ACTIVITIES:

               

Purchases of property and equipment

    (30 )     (14 )

Purchases of marketable securities

    (36,164 )      

Proceeds from maturities of marketable securities

    3,307        

Net cash used in investing activities

    (32,887 )     (14 )

CASH FLOWS FROM FINANCING ACTIVITIES:

               

Dividends paid

    (4,606 )     (4,608 )

Net cash used in financing activities

    (4,606 )     (4,608 )

Effect of exchange rates on cash, cash equivalents and restricted cash

    (92 )     (179 )

Net decrease in cash, cash equivalents and restricted cash

    (40,604 )     (8,141 )

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period

    56,217       69,746  

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period

  $ 15,613     $ 61,605  

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

               

Right-of-use assets obtained in exchange for operating lease liabilities

  $ 196     $ (125 )

 

6